Comparisons of Two Types of Armeo Robot for Upper Extremities
Launched by NATIONAL REHABILITATION CENTER, SEOUL, KOREA · Mar 7, 2018
Trial Information
Current as of May 25, 2025
Unknown status
Keywords
ClinConnect Summary
The purpose of this study is to compare two types of robot. The robot used in this experiment was Armeo power and Armeo spring. Armeo power could provide assistive force via motor, on the other hand, Armeo spring could not provide any assist.
Thus the results from this study might suggest usefulness of motorized robot.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hemiplegic patients secondary to first cerebrovascular accidents
- • Onset ≥ 3 months
- • 26 ≤ Fugl-Meyer Assessment score ≤ 50
- • 3 ≤ Shoulder or elbow MRC scale ≤ 4
- • Shoulder or elbow flexor spasticity modified ashworth scale ≤ 1+
- • Cognitively intact enough to understand and follow the instructions from the investigator
- Exclusion Criteria:
- • History of surgery of affected upper limb
- • Fracture of affected upper limb
About National Rehabilitation Center, Seoul, Korea
The National Rehabilitation Center in Seoul, Korea, is a leading institution dedicated to advancing rehabilitation science and improving patient outcomes through innovative research and clinical trials. With a focus on enhancing the quality of life for individuals with disabilities, the center integrates multidisciplinary expertise in rehabilitation medicine, therapy, and technology. By engaging in rigorous clinical research, the National Rehabilitation Center aims to develop evidence-based practices and therapies that address the diverse needs of patients, fostering a commitment to excellence in rehabilitation services and contributing to the global knowledge base in this vital field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Joon-Ho Shin, MS
Principal Investigator
National Rehabilitation Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials